
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mace (Myristica fragrans aril) contains macelignan as its primary bioactive compound, demonstrating anti-inflammatory activity through COX-2 and iNOS inhibition with an IC₅₀ of 82.19 μg/ml. The spice exhibits significant antioxidant capacity via free radical scavenging mechanisms, achieving EC₅₀ values of 13.41 μg/ml in DPPH assays.

Reported Benefits (Provisional)
Origin & History

Mace Spice is the aril, or outer lacy covering, of the nutmeg seed (*Myristica fragrans*), a tropical evergreen tree native to the Maluku Islands of Indonesia, India, and Sri Lanka. It is prized for its distinct aromatic profile and its rich concentration of bioactive compounds, offering diverse functional benefits.
Research Narrative (Provisional)
Numerous in vitro and animal studies, alongside preliminary human trials, support Mace Spice's cognitive-enhancing, anti-inflammatory, and antimicrobial properties. Research highlights the neuroprotective effects of myristicin and elemicin, and the digestive benefits of its essential oils, though more large-scale human RCTs are needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Bioactives: Myristicin, elemicin, eugenol, sabinene, polyphenols - Minerals: Copper, manganese, magnesium
Reported Mechanism (Provisional)
Macelignan and malabaricone C suppress LPS-induced nitric oxide production and inhibit cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression in immune cells. The antioxidant effects operate through direct free radical scavenging mechanisms, while anticancer activity involves suppression of calcium influx and nitric oxide reduction.
Clinical Narrative (Provisional)
Laboratory studies demonstrate mace's ethanolic extract (EMACE) exhibits anti-inflammatory activity with an IC₅₀ of 82.19 μg/ml against LPS-induced nitric oxide production. Antioxidant testing shows promising results with EC₅₀ values of 13.41 μg/ml (DPPH) and 12.44 μg/ml (ABTS assays). Cytotoxicity studies against gastric cancer cells revealed an IC₅₀ of 26.06 μg/ml, though research remains limited to in vitro and animal models. Large-scale human randomized controlled trials are needed to establish clinical efficacy and therapeutic dosing parameters.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







